Suppr超能文献

Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma.

作者信息

De Geer Anna, Carlson Lena-Maria, Kogner Per, Levitskaya Jelena

机构信息

Department of Oncology-Pathology, Cancer Centrum Karolinska, Karolinska Institutet, 17176, Stockholm, Sweden.

出版信息

Cancer Immunol Immunother. 2008 May;57(5):731-43. doi: 10.1007/s00262-007-0412-2. Epub 2007 Oct 26.

Abstract

Neuroblastoma (NB) is often described as an unfavorable target for both HLA-restricted and death receptor-mediated elimination by cytotoxic T lymphocytes (CTLs) due to low or absent HLA class I and caspase-8 expression. We investigated the effects of soluble factors released by CTLs activated by TCR triggering (named as activated supernatant; AS) on the levels and composition of cell surface molecules involved in HLA-restricted and HLA-independent NB cell recognition (surface immune phenotype). Using a panel of long-term propagated NB cell lines and freshly isolated primary human NB cells, we analyzed surface expression of the (1) cognate receptors for TNFalpha, Fas and TRAIL; (2) HLA class I and II heterodimers; (3) adhesion molecules; (4) the intracellular expression and activation of caspase-8, as well as (5) the susceptibility of NB cells to death receptor-mediated killing prior to and after exposure to AS. The exposure of NB cells to soluble factors released by activated CTLs skewed the surface immune phenotype of both long term cultured and primary NB cells, induced the expression and activation of caspase-8 and increased the susceptibility of tumor cells to lysis by TRAIL and Fas-agonistic antibody. Blocking experiments identified IFNgamma and TNFalpha as main factors responsible for modulating the surface antigens of NB cells by AS. Our data suggest that recruitment of CTLs activated on third party targets into the vicinity of the NB tumor mass, may override the "silent" immune phenotype of NB cells via the action of soluble factors.

摘要

相似文献

1
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma.
Cancer Immunol Immunother. 2008 May;57(5):731-43. doi: 10.1007/s00262-007-0412-2. Epub 2007 Oct 26.
8
Major histocompatibility complex-restricted lysis of neuroblastoma cells by autologous cytotoxic T lymphocytes.
J Immunother. 2001 Jul-Aug;24(4):305-11. doi: 10.1097/00002371-200107000-00006.
10
Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.
PLoS One. 2016 Oct 7;11(10):e0164401. doi: 10.1371/journal.pone.0164401. eCollection 2016.

引用本文的文献

1
T cells in the microenvironment of solid pediatric tumors: the case of neuroblastoma.
Front Immunol. 2025 Feb 28;16:1544137. doi: 10.3389/fimmu.2025.1544137. eCollection 2025.
2
Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions.
Front Immunol. 2020 Apr 24;11:501. doi: 10.3389/fimmu.2020.00501. eCollection 2020.
5
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors.
Cancer Immunol Immunother. 2013 Apr;62(4):773-85. doi: 10.1007/s00262-012-1384-4. Epub 2012 Dec 22.

本文引用的文献

1
Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis.
Cell Death Differ. 2007 Aug;14(8):1486-96. doi: 10.1038/sj.cdd.4402152. Epub 2007 May 4.
2
TRAIL death receptors and cancer therapeutics.
Toxicol Appl Pharmacol. 2007 Nov 1;224(3):284-9. doi: 10.1016/j.taap.2006.12.007. Epub 2006 Dec 15.
5
Evaluation of IFN-gamma effects on apoptosis and gene expression in neuroblastoma--preclinical studies.
Biochim Biophys Acta. 2006 Oct;1763(10):1000-10. doi: 10.1016/j.bbamcr.2006.06.014. Epub 2006 Aug 9.
6
Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms.
Nat Clin Pract Oncol. 2006 Jul;3(7):388-98. doi: 10.1038/ncponc0538.
7
5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.
Oncogene. 2006 Aug 24;25(37):5125-33. doi: 10.1038/sj.onc.1209518. Epub 2006 Apr 10.
8
Halting neuroblastoma metastasis by controlling integrin-mediated death.
Cell Cycle. 2006 Apr;5(7):681-5. doi: 10.4161/cc.5.7.2615. Epub 2006 Apr 1.
9
FasL gene therapy: a new therapeutic modality for head and neck cancer.
Cancer Gene Ther. 2006 Aug;13(8):739-45. doi: 10.1038/sj.cgt.7700951. Epub 2006 Mar 17.
10
Potentiation of neuroblastoma metastasis by loss of caspase-8.
Nature. 2006 Jan 5;439(7072):95-9. doi: 10.1038/nature04323.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验